142 related articles for article (PubMed ID: 6798588)
1. Lithium stimulates thromboxane B2 formation in human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
Uotila P; Matintalo M; Dahl ML
Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet aggregation and thromboxane production by pinacidil.
Goodman RP; Little DM; Wright JT
Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
[No Abstract] [Full Text] [Related]
5. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
[No Abstract] [Full Text] [Related]
6. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
[TBL] [Abstract][Full Text] [Related]
7. OKY-1581: a selective inhibitor of thromboxane synthesis in vivo and in vitro.
Smith JB; Jubiz W
Prostaglandins; 1981 Sep; 22(3):353-63. PubMed ID: 7302264
[TBL] [Abstract][Full Text] [Related]
8. Influence of strontium chloride on blood platelet function.
Togna G; Gallozzi S; Caprino L
Arch Toxicol Suppl; 1989; 13():366-9. PubMed ID: 2505737
[No Abstract] [Full Text] [Related]
9. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
Burns GB; Dodge JA
Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
[TBL] [Abstract][Full Text] [Related]
10. Transformations of exogenous arachidonic acid in human platelets in the presence of oleic- and eicosapentaenoic acids.
Srivastava KC
Prostaglandins Leukot Med; 1985 Apr; 18(1):31-7. PubMed ID: 2987977
[TBL] [Abstract][Full Text] [Related]
11. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
Harris RH; Nichols R; Schmeling JW; Ramwell PW
Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
[No Abstract] [Full Text] [Related]
14. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.
Beatty CH; Howard CF; Hoskins MK; Herrington PT
Atherosclerosis; 1985 Apr; 55(1):1-13. PubMed ID: 3924062
[TBL] [Abstract][Full Text] [Related]
15. A dominant role of thromboxane formation in secondary aggregation of platelets.
Meyers KM; Seachord CL; Holmsen H; Smith JB; Prieur DJ
Nature; 1979 Nov; 282(5736):331-3. PubMed ID: 503210
[No Abstract] [Full Text] [Related]
16. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
Sinha AK; Rao AK; Willis J; Colman RW
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
Hung SC; Ghali NI; Venton DL; Le Breton GC
Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation.
Agradi E; Petroni A; Socini A; Galli C
Prostaglandins; 1981 Aug; 22(2):255-66. PubMed ID: 6794104
[TBL] [Abstract][Full Text] [Related]
19. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]